Boehringer looks for Pradaxa boost from now FDA-approved antidote

Carly Helfand

The lack of an to reverse the effects of new-age anticoagulants has kept some doctors prescribing them. But now, Ingelheim is hoping that'll change.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS